Overview Fundamentals API Earnings EOD API Sample Code Pricing

CERo Therapeutics Holdings, Inc. Common Stock (CERO NASDAQ) stock market data APIs

$0.0879 -0.01(-10.7%) as of September 13, 2024
Price chart is built with Anychart

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.

CERo Therapeutics Holdings, Inc. Common Stock Financial Data Overview

0.0936
0.0879
-
0.1025
0.0852
0.072-12.8
6 532 K
51 354 K
0
-0.1512
-0.437
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CERO',
Type: 'Common Stock',
Name: 'CERo Therapeutics Holdings, Inc. Common Stock',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG012LSLG64',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2024-02-15',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

CERo Therapeutics Holdings, Inc. Common Stock Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -1.19
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get CERo Therapeutics Holdings, Inc. Common Stock Earnings via APIs

  • Latest Release 2024-06-30
  • EPS/Forecast NaN

Get CERo Therapeutics Holdings, Inc. Common Stock End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com